222 related articles for article (PubMed ID: 30144391)
1. miR-200a-5p augments cardiomyocyte hypertrophy induced by glucose metabolism disorder via the regulation of selenoproteins.
Yang T; Liu T; Cao C; Xu S
J Cell Physiol; 2019 Apr; 234(4):4095-4103. PubMed ID: 30144391
[TBL] [Abstract][Full Text] [Related]
2. A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
Lu Y; Wu F
Gene; 2018 Mar; 648():21-30. PubMed ID: 29339068
[TBL] [Abstract][Full Text] [Related]
3. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
4. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
5. miR-200a-5p regulates myocardial necroptosis induced by Se deficiency via targeting RNF11.
Yang T; Cao C; Yang J; Liu T; Lei XG; Zhang Z; Xu S
Redox Biol; 2018 May; 15():159-169. PubMed ID: 29248830
[TBL] [Abstract][Full Text] [Related]
6. The regulatory effects of miR-138-5p on selenium deficiency-induced chondrocyte apoptosis are mediated by targeting SelM.
Chi Q; Luan Y; Zhang Y; Hu X; Li S
Metallomics; 2019 Apr; 11(4):845-857. PubMed ID: 30869711
[TBL] [Abstract][Full Text] [Related]
7. MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
Wang W; Wu C; Ren L; Bao Y; Han Y; Li C; Li Y
Exp Cell Res; 2020 Sep; 394(2):112140. PubMed ID: 32535037
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
11. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
13. MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy.
Zhao Y; Ponnusamy M; Liu C; Tian J; Dong Y; Gao J; Wang C; Zhang Y; Zhang L; Wang K; Li P
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2871-2881. PubMed ID: 28782654
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200a-3p Is a Positive Regulator in Cardiac Hypertrophy Through Directly Targeting WDR1 as Well as Modulating PTEN/PI3K/AKT/CREB/WDR1 Signaling.
Yang X; Chen G; Chen Z
J Cardiovasc Pharmacol; 2019 Nov; 74(5):453-461. PubMed ID: 31651553
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
Song G; Zhu L; Ruan Z; Wang R; Shen Y
Biochem Biophys Res Commun; 2019 Nov; 519(4):682-688. PubMed ID: 31543343
[TBL] [Abstract][Full Text] [Related]
16. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q
Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.
Hirt MN; Werner T; Indenbirken D; Alawi M; Demin P; Kunze AC; Stenzig J; Starbatty J; Hansen A; Fiedler J; Thum T; Eschenhagen T
J Mol Cell Cardiol; 2015 Apr; 81():1-9. PubMed ID: 25633833
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG1 exerts a protective role in cardiomyocytes hypertrophy via targeting miR-15a-5p/HMGA1 axis.
Yan SM; Li H; Shu Q; Wu WJ; Luo XM; Lu L
Cell Biol Int; 2020 Apr; 44(4):1009-1019. PubMed ID: 31889385
[TBL] [Abstract][Full Text] [Related]
19.
Ming S; Shui-Yun W; Wei Q; Jian-Hui L; Ru-Tai H; Lei S; Mei J; Hui W; Ji-Zheng W
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29440459
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-339-5p promotes isoproterenol-induced cardiomyocyte hypertrophy by targeting VCP to activate the mTOR signaling.
Bi X; Zhang Y; Yu Y; Yuan J; Xu S; Liu F; Ye J; Liu P
Cell Biol Int; 2022 Feb; 46(2):288-299. PubMed ID: 34854520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
